Author:
Lin Zhicheng,Lang Zi-Qiang,Guo Lingzhong,Walker Dawn C,Matella Malwina,Wang Mengxiao,Murdoch Craig
Abstract
Abstract
Electrical impedance spectroscopy (EIS) is a powerful tool used to investigate the properties of materials and biological tissues. This study presents one of the first applications of EIS for the detection and classification of oral potentially malignant disorders (OPMDs) and oral cancer. We aimed to apply EIS in conjunction with deep learning to assist the clinical diagnosis of OPMD and oral cancer as a non-invasive diagnostic technology. Currently, the diagnosis of OPMD and oral cancer relies on clinical examination and histopathological analysis of invasive scalpel tissue biopsies, which is stressful for patients, time-consuming for clinicians and subject to histopathological interobserver variation in diagnosis, although recent advances in artificial intelligence may circumvent discrepancy. Here we developed a novel deep learning convolutional neural network (CNN)-based method to automatically differentiate normal, OPMD and malignant oral tissues using EIS measurements. EIS readings were initially taken from untreated or glacial acetic acid-treated porcine oral mucosa and analyzed via CNN to determine if this method could discriminate between normal and damaged oral epithelium. CNN models achieved area under the curve (AUC) values of 0.92 ± 0.03, with specificity 0.95 and sensitivity 0.84, showing good discrimination. EIS data from ventral tongue and floor-of-the-mouth were collected from 51 healthy humans and 11 patients with OPMD and oral cancer. When a binary classification (low or high risk of malignancy) was applied, the best CNN model achieved an AUC 0.91 ± 0.1, with accuracy 0.91 ± 0.05, specificity 0.97 and sensitivity 0.74. These results demonstrate the considerable potential of EIS in combination with CNN models as an adjunctive non-invasive diagnostic tool for OPMD and oral cancer.
Funder
Engineering and Physical Sciences Research Council
Yorkshire Cancer Research
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Sung, H. & ‘Global Cancer Statistics. : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries’, CA. Cancer J. Clin., vol. 71, no. 3, pp. 209–249, May 2021, (2020). https://doi.org/10.3322/caac.21660
2. Bray, F. et al. ‘Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries’, CA. Cancer J. Clin., vol. 68, no. 6, pp. 394–424, Nov. (2018). https://doi.org/10.3322/caac.21492
3. Muller, P., Belot, A., Morris, M., Rachet, B. & ‘Oral Health Foundation. July, : The State of Mouth Cancer UK Report 2020/21.’, Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine, 2022. [Online]. Available: (2016). Available from http://csg.lshtm.ac.uk/rare-cancers/.Accessed www.mouthcancer.org.
4. Shahul Hameed, K. A., Shaheer Abubacker, K. A., Banumathi, A. & Ulaganathan, G. ‘Immunohistochemical analysis of oral cancer tissue images using support vector machine’, Measurement, vol. 173, no. 108476, (2021). https://doi.org/10.1016/j.measurement.2020.108476
5. Speight, P. M. et al. Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 120 (4), 474–482e2. https://doi.org/10.1016/j.oooo.2015.05.023 (Oct. 2015).